首页> 外文会议>2011 Asia-Pacific Conference of tumor biology and medicine >RNA-seq Analyses Generate Comprehensive Transcriptomic Landscape and Reveal Complex Transcript Patterns in Hepatocellular Carcinoma
【24h】

RNA-seq Analyses Generate Comprehensive Transcriptomic Landscape and Reveal Complex Transcript Patterns in Hepatocellular Carcinoma

机译:RNA序列分析产生肝细胞癌的综合转录组景观和揭示复杂的转录模式。

获取原文
获取原文并翻译 | 示例

摘要

RNA-seq is a powerful tool for comprehensive characterization of whole transcriptome at both gene and exon levels and with a unique ability of identifying novel splicing variants. To date, RNA-seq analysis of HBV-related hepatocellular carcinoma (HCC) has not been reported. In this study, we performed transcriptome analyses for 10 matched pairs of cancer and non-cancerous tissues from HCC patients on Solexa/IUumina GAII platform. On average, about 21.6 million sequencing reads and 10.6 million aligned reads were obtained for samples sequenced on each lane, which was able to identify > 50% of all the annotated genes for each sample. Furthermore, we identified 1,378 significantly differently expressed genes (DEGs) and 24, 338 differentially expressed exons (DEEs). Comprehensive function analyses indicated that cell growth-related, metabolismrelated and immune-related pathways were most significantly enriched by DEGs, pointing to a complex mechanism for HCC carcinogenesis. Positional gene enrichment analysis showed that DEGs were most significantly enriched at chromosome 8q21.3-24.3. The most interesting findings were from the analysis at exon levels where we characterized three major patterns of expression changes between gene and exon levels, implying a much complex landscape of transcript-specific differential expressions in HCC. Finally, we identified a novel highly up-regulated exon-exon junction in ATAD2 gene in HCC tissues. Overall, to our best knowledge, our study represents the most comprehensive characterization of HBVrelated HCC transcriptome including exon level expression changes and novel splicing variants, which illustrated the power of RNA-seq and provided important clues for understanding the molecular mechanisms of HCC pathogenesis at system-wide levels.
机译:RNA-seq是在基因和外显子水平上全面表征整个转录组的有力工具,并且具有识别新型剪接变体的独特能力。迄今为止,尚未报道HBV相关肝细胞癌(HCC)的RNA-seq分析。在这项研究中,我们在Solexa / IUumina GAII平台上对来自HCC患者的10对匹配的癌症和非癌组织进行了转录组分析。对于每个泳道上测序的样品,平均获得约2160万个测序读物和1060万个比对读物,这能够识别每个样品中所有带注释基因的> 50%。此外,我们确定了1378个差异显着的基因(DEG)和24、338个差异表达的外显子(DEE)。综合功能分析表明,DEGs最显着地丰富了细胞生长相关,代谢相关和免疫相关的途径,表明了HCC致癌的复杂机制。位置基因富集分析表明DEGs在8q21.3-24.3。染色体上最富集。最有趣的发现来自外显子水平的分析,在此我们表征了基因和外显子水平之间表达变化的三种主要模式,这暗示了肝癌中转录特异性差异表达的复杂性。最后,我们在肝癌组织中的ATAD2基因中鉴定了一种新型高度上调的外显子-外显子连接。总体而言,据我们所知,我们的研究代表了HBV相关HCC转录组的最全面表征,包括外显子水平表达变化和新颖的剪接变体,这说明了RNA-seq的功能,并为了解系统中HCC发病机理的分子机制提供了重要线索。级别。

著录项

  • 来源
  • 会议地点 Shanghai(CN)
  • 作者单位

    State Key Laboratory of Cancer Biology, Cell Engineering Research Center Department of Cell Biology, Fourth Military Medical University, Xi'an, 710032, China;

    Department of Comprehensive Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical Universitv. Shanghai. 200438. P. R. China;

    Department of Comprehensive Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical Universitv. Shanghai. 200438. P. R. China;

    State Key Laboratory of Cancer Biology, Cell Engineering Research Center Department of Cell Biology, Fourth Military Medical University, Xi'an, 710032, China;

    State Key Laboratory of Cancer Biology, Cell Engineering Research Center Department of Cell Biology, Fourth Military Medical University, Xi'an, 710032, China;

    Systems Biology Division, Zhejiang-California International Nanosystems Institute (ZCNI),Zhejiang University, Hangzhou, 310029, China Department of Urology, University of Washington, Seattle, WA 98195;

    State Key Laboratory of Cancer Biology, Cell Engineering Research Center Department of Cell Biology, Fourth Military Medical University, Xi'an, 710032, China;

    State Key Laboratory of Cancer Biology, Cell Engineering Research Center Department of Cell Biology, Fourth Military Medical University, Xi'an, 710032, China;

    Systems Biology Division, Zhejiang-California International Nanosystems Institute (ZCNI),Zhejiang University, Hangzhou, 310029, China;

    Systems Biology Division, Zhejiang-California International Nanosystems Institute (ZCNI),Zhejiang University, Hangzhou, 310029, China;

    Systems Biology Division, Zhejiang-California International Nanosystems Institute (ZCNI),Zhejiang University, Hangzhou, 310029, China;

    State Key Laboratory of Cancer Biology, Cell Engineering Research Center Department of Cell Biology, Fourth Military Medical University, Xi'an, 710032, China;

    Institute of Life Science and Biotechnology, Beijing Jiaotong University, Beijing, 100044, P. R.China;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 一般性问题;
  • 关键词

  • 入库时间 2022-08-26 14:26:47

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号